Sender Co & Partners »

Taysha Gene Therapies shares owned by Sender Co & Partners

Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by Sender Co & Partners from 13F filings

Historical chart of Sender Co & Partners investment in Taysha Gene Therapies

Tip: Access up to 7 years of quarterly data

All positions including Taysha Gene Therapies held by Sender Co & Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taysha Gene Therapies by Sender Co & Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $89k 27k 3.27

More positions owned by Sender Co & Partners

Invesco Qqq Tr Put Put Option
Spdr S&p 500 Etf Tr Put Put Option
Ishares Tr Russell 2000 Etf Put Option (IWM)
Kenvue Call Call Option
Select Sector Spdr Tr Sbi Healthcare (XLV)
Medpace Hldgs Put Put Option
Apple Put Put Option
Kenvue (KVUE)
Boeing Company (BA)
Crowdstrike Hldgs Put Put Option
Constellation Energy (CEG)
Vaneck Etf Trust Semiconductr Etf Put Option (SMH)
Keurig Dr Pepper Call Call Option
Seagate Technology Hldngs Pl Put Put Option
Zeta Global Holdings Corp Call Call Option

View all positions for Sender Co & Partners

Top funds holding Taysha Gene Therapies

Rtw Investments
RA Capital Management
venBio Select Advisor
Morgan Stanley
BlackRock
FMR
Goldman Sachs Group
Vanguard Group
Siren
Octagon Capital Advisors
Point72 Asset Management
State Street Corporation
Vestal Point Capital
Deerfield Management Company
Polar Capital Holdings

View all funds holding Taysha Gene Therapies